Cheshire, CT, United States of America

Shouming Li

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 8.8

ph-index = 4

Forward Citations = 48(Granted Patents)


Location History:

  • Chesire, CT (US) (2012)
  • Cheshire, CT (US) (2006 - 2013)

Company Filing History:


Years Active: 2006-2013

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Shouming Li

Introduction

Shouming Li is a notable inventor based in Cheshire, Connecticut, who has made significant contributions to the field of antiviral research. With a total of eight patents to his name, he has focused on developing innovative compounds that target viral replication, particularly in relation to Hepatitis C.

Latest Patents

Among his latest patents is the invention of 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication. This invention provides a series of peptides that are effective as antiviral agents, particularly against Hepatitis C virus replication. The patent outlines the pharmaceutical compositions that can include these peptides, either as the sole active agent or in combination with other therapeutic agents. Another significant patent involves thiazole compounds, which also demonstrate potent antiviral activity. These compounds are designed to inhibit the assembly of the HCV replication complex and can be used in treating various infectious diseases.

Career Highlights

Shouming Li is currently associated with Achillion Pharmaceuticals, Inc., where he continues to advance his research in antiviral therapies. His work has been instrumental in developing new treatment options for patients suffering from viral infections.

Collaborations

Shouming Li has collaborated with notable colleagues such as Avinash S Phadke and Dawei Chen, contributing to a dynamic research environment focused on innovative solutions for viral diseases.

Conclusion

Shouming Li's contributions to antiviral research through his patents and collaborations highlight his commitment to improving treatment options for viral infections. His work continues to pave the way for advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…